Navigation Links
LifeScan Fulfills Exclusive U.S. Agreement With Medtronic
Date:5/9/2011

MILPITAS, Calif., May 9, 2011 /PRNewswire/ -- LifeScan, Inc., makers of the top-selling OneTouch® Brand of Blood Glucose Monitoring Systems for people with diabetes, has fulfilled the terms of its exclusive, three-year agreement to provide Medtronic customers in the U.S. with the OneTouch® UltraLink® Blood Glucose Meter that wirelessly transmits glucose values to Medtronic MiniMed Paradigm® insulin pumps and Guardian® REAL-Time continuous glucose monitoring (CGM) systems.

"The Medtronic/LifeScan alliance has been quite successful.  Together, we've raised awareness of insulin pump therapy and the benefits of frequent blood glucose testing for patients who use insulin.  We are grateful for the opportunity to serve these patients," said Michel Paul, Company Group Chairman, Johnson & Johnson Family of Diabetes Companies, which includes LifeScan.

LifeScan will continue to provide OneTouch UltraLink Systems to Medtronic to meet the needs of new and existing U.S. users of their products until an alternate system becomes available from Medtronic's new, contracted U.S. meter supplier.  In addition, all OneTouch UltraLink Systems currently in the market will continue to operate.  Patients can continue to use their OneTouch UltraLink Systems based on their personal preference and other factors, such as HCP recommendations or lower insurance co-pays for OneTouch® Ultra® Blue Test Strips, which are used by the OneTouch UltraLink System.

Going forward, LifeScan and Animas, both members of the Johnson & Johnson Family of Diabetes Companies, will expand their existing collaboration and joint product development programs to deliver integrated products, tools and services for insulin patients.  The companies co-developed the current OneTouch® Ping® System, the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote.  Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"Through our continued work with Animas we hope to further empower patients to more easily and effectively manage their glucose levels while easing the burden of patient education on healthcare providers," said Mr. Paul.

Four operating units comprise the Johnson & Johnson Family of Diabetes Companies with the goals of providing professional and community education, advanced products and services, and advocacy and support to people living with diabetes and their families.  These companies include: LifeScan, Inc., a world leader in blood glucose monitoring;  Animas Corporation, maker of innovative insulin delivery systems; Children with Diabetes, Inc., a community offering support and education for children, adults and their families living with diabetes; and the Johnson & Johnson Diabetes Institute, LLC, a global initiative to improve care and better outcomes worldwide through educational programs.

About LifeScan:  LifeScan is the leading blood glucose monitoring company in the U.S.  More than 5 million people in the U.S. depend on LifeScan's OneTouch® Brand Products for simple testing and accurate results to help them manage their diabetes.  OneTouch® is the most recommended brand of meters by Healthcare Professionals in the U.S., including Endocrinologists, Primary Care Physicians and Diabetes Educators.  97% of patients, including those with Medicare, are insured for OneTouch® Brand Products according to MediMedia Formulary Compass, March 2011 and CMS Medicare Part B enrollment.  For more information on diabetes care and OneTouch® Products and services, visit www.OneTouch.com.

About Animas Corporation:  Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas® 2020 insulin pump, ezManager® MAX software, and the OneTouch Ping Glucose Management System.  Animas, from the Latin word meaning "true inner self or soul," has been committed since 1996 to meeting individual patient needs through the development of life-performance technology and unparalleled customer service 24 hours a day, 7 days a week, 365 days a year.


'/>"/>
SOURCE LifeScan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prometheus Obtains Exclusive US Commercialization Rights for RENCAREX®
2. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
3. RushCard Offers Members Exclusive Discounts on Health Care Services
4. Biofield Corporations 51% Owned Subsidiary Agrees to Deal Appointing McKinley Infocapital as Korean Exclusive Distributor of Breast Cancer Diagnostic System; Contract has Potential Value of up to $15.3 Million
5. KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies
6. Telome Health, Inc. Launches With Exclusive IP Portfolio
7. Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio
8. Fujifilms Exclusive Software Advances Cardiovascular Reporting Capabilities
9. PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry
10. Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter
11. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... 27, 2016 , ... In response to meager public awareness, ... of the plight of aphasia. In collaboration with the American Aphasia Association, a ... The link between stroke and aphasia is relatively unknown, but through collaboration with ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Aimed at nurses ... interest stories, which come courtesy of leaders in the nursing and health care industry. ... leading advocates and associations—namely Abilene Christian University. , As the nursing industry is ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
Breaking Medicine News(10 mins):